FDA Finalizes Guidance On ‘Unique Challenges’ Of Psychedelic Research And Schedules Hearing On Therapeutic Uses
June 13, 2015 The Club Drug Emerging As a Popular Antidepressant The limitations of SSRIs are widely known. Could ketamine be the answer?
